Top Banner
Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08
46

Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Jan 11, 2016

Download

Documents

Clyde Dalton
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. Shahram Yazdani

Venture Capital Investment

Shahid Beheshti University of Medical SciencesSchool of Medical Education

Strategic Policy Sessions: 08

Page 2: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Pharmaceutical Product Development Timeline

1-5 Years1-5 Years

R&DR&D

1: 10,0001: 10,000

$ 10-20 M$ 10-20 M

DurationDuration

PhasePhase

Success RateSuccess Rate

InvestmentInvestment

Page 3: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Pharmaceutical Product Development Timeline

1-5 Years1-5 Years 1-2 Years1-2 Years

R&DR&D PreclinicalPreclinical

1: 10,0001: 10,000 1: 1001: 100

$ 10-20 M$ 10-20 M $ 10-20 M$ 10-20 M

DurationDuration

PhasePhase

Success RateSuccess Rate

InvestmentInvestment

Page 4: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Pharmaceutical Product Development Timeline

1-5 Years1-5 Years 1-2 Years1-2 Years 1 Year1 Year

R&DR&D PreclinicalPreclinical Clinical IClinical I

1: 10,0001: 10,000 1: 1001: 100 1: 101: 10

$ 10-20 M$ 10-20 M $ 10-20 M$ 10-20 M $ 20-30 M$ 20-30 M

DurationDuration

PhasePhase

Success RateSuccess Rate

InvestmentInvestment

Page 5: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Pharmaceutical Product Development Timeline

1-5 Years1-5 Years 1-2 Years1-2 Years 1 Year1 Year 1-2 Years1-2 Years 1-3 Years1-3 Years

R&DR&D PreclinicalPreclinical Clinical IClinical I Clinical IIClinical II Clinical IIIClinical III

1: 10,0001: 10,000 1: 1001: 100 1: 101: 10 1: 101: 10 1: 51: 5

$ 10-20 M$ 10-20 M $ 10-20 M$ 10-20 M $ 20-30 M$ 20-30 M $ 30-60 M$ 30-60 M

DurationDuration

PhasePhase

Success RateSuccess Rate

InvestmentInvestment

Page 6: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

A Long and Risky Path

A lot of things have to happen to transform a start-up, consisting of a few founders with an idea, into a modern corporation, which is a complex institution.

Page 7: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Need for Money

As a rule of thumb, for every $ spent on R&TD, ten $ will be needed to bring the product into production and as much as one hundred $ to bring it to the market.

It follows then that almost any project is going to require additional finance if it is to be successfully exploited.

Page 8: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capital

A company requires an average of $16 million in venture capital during the first five start-up years,

Page 9: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

A risky investment

Christopher Columbus seeking financing from Queen Isabella and King Ferdinand in an early example of venture capital

Page 10: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capital Industry

History In the early 1950s and 1960s, individual

investors were the archetypal venture investor. Venture capital has grown from a small

investment pool in the 1960s and early 1970s Currently it is more a mainstream asset class

that is a viable and significant part of the institutional and corporate investment portfolio.

Page 11: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Definition of venture capital

Venture capital is a type of financial intermediary that is specialized in the financing of entrepreneurial companies.

Page 12: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Well-known firms that have received VC financing

Apple Cisco Microsoft Netscape Sun Microsystems Staples Starbucks Google Amazon

Page 13: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Need for Money

It is a characteristic of most entrepreneurs that they have very little money; usually they will start their business with whatever they can afford, augmented by loans or investments from family and friends, plus, in many cases finance from regional or national grants or awards.

Page 14: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Sources of Finance for Innovation

In general terms, innovation finance comes from the public sector, banks or from private finance-sources.

Which of these is appropriate to a specific case depends on a number of factors: the stage of development of the project, the

size of the innovating company, the amount of money required.

Page 15: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

IPO: Initial Public Offering

Page 16: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Financial SupportResearchGrants

ResearchGrants

Main Role

New FirmNew Firm Mature SMEMature SME Large CompanyLarge Company

ProductProduct

ResearcherResearcher InventorInventor EntrepreneurEntrepreneur BusinessmanBusinessman

Business PlanBusiness Plan

PropositionalKnowledge

PropositionalKnowledge

PrescriptiveKnowledgePrescriptiveKnowledge

BasicResearch

BasicResearch

AppliedResearchApplied

ResearchProduct Design &

DevelopmentProduct Design &

Development ManufacturingManufacturing

Pre-productionPrototype

Pre-productionPrototype

EngineeringPrototype

EngineeringPrototype

Financial SupporterResearchFoundersResearchFounders

Page 17: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Research Stage

Funding will come, usually in the form of grants, primarily from: Public Sector - national governments, regional

authorities or the European Commission; Corporate - industrial/commercial companies,

industrial research associations, charities Neither banks nor any form of equity investor

is likely to be interested at this stage.

Page 18: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Public Sector

Grants Awards Investment support schemes

Page 19: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Financial SupportSeedFinanceSeed

FinanceResearch

GrantsResearch

Grants

Main Role

New FirmNew Firm Mature SMEMature SME Large CompanyLarge Company

ProductProduct

ResearcherResearcher InventorInventor EntrepreneurEntrepreneur BusinessmanBusinessman

Business PlanBusiness Plan

PropositionalKnowledge

PropositionalKnowledge

PrescriptiveKnowledgePrescriptiveKnowledge

BasicResearch

BasicResearch

AppliedResearchApplied

ResearchProduct Design &

DevelopmentProduct Design &

Development ManufacturingManufacturing

Pre-productionPrototype

Pre-productionPrototype

EngineeringPrototype

EngineeringPrototype

Financial SupporterResearchFoundersResearchFounders

AngelInvestors

AngelInvestors

Page 20: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Development Stage

As the project reaches the stage where a prototype of pilot plant can be built to demonstrate its feasibility. Seed Capital - venture funds prepared to

make pre-start-up investments in the technology. Pre start-up funding may be in the form of loans, convertible to equity when the company is formed.

Page 21: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Friends And Family

A "helping hand" rather than a serious investment

Cannot be relied upon for follow-up finance

May not have useful commercial contacts Generally less than about $15'000

Page 22: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Angel Investors or Business Angels

75% invest between $20'000 and $200'000 and up to $1'000'000

Sometime co-financing with others ("syndicated" investments)

Usually invest on a very early-stage company (demo, 2-3 employees)

Page 23: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Angel Investors or Business Angels

Wealthy individuals who provide capital for startup and emerging businesses.

Usually invest locally and in projects they understand

Quick decisions Likely to take a "hands on" approach to their

investment

Page 24: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Angel Investors or Business Angels

There are 250,000 or more such wealthy individuals, or angels, in the US, 100,000 of whom are active.

Angels invest $5 to $10 billion annually in 20,000 to 30,000 companies

Page 25: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Financial SupportSeedFinanceSeed

FinanceStart-up

Venture CapitalStart-up

Venture CapitalResearch

GrantsResearch

Grants

Main Role

New FirmNew Firm Mature SMEMature SME Large CompanyLarge Company

ProductProduct

ResearcherResearcher InventorInventor EntrepreneurEntrepreneur BusinessmanBusinessman

Business PlanBusiness Plan

PropositionalKnowledge

PropositionalKnowledge

PrescriptiveKnowledgePrescriptiveKnowledge

BasicResearch

BasicResearch

AppliedResearchApplied

ResearchProduct Design &

DevelopmentProduct Design &

Development ManufacturingManufacturing

Pre-productionPrototype

Pre-productionPrototype

EngineeringPrototype

EngineeringPrototype

Financial SupporterResearchFoundersResearchFounders

AngelInvestors

AngelInvestors

VentureCapital Firm

VentureCapital Firm

Page 26: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Start-up Stage

Finance provided to companies for product development and initial marketing.

Companies may be in the process of being set up or may have been in business for a short time, but have not sold their product commercially.

Page 27: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capitalists

The Venture Capital Fund Management Company manages the funds of its investors (shareholders) and, in due course, returns the profits, after deduction of expenses and fees, to those investors.

Page 28: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capitalists

Seek investments in firms with high-growth possibilities

Not usually interested below $500,000 Slow decisions but very thorough Add value, not just financial assistance No outflow of cash in interest on loans or

dividends to investors before exit

Page 29: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Risk Taker or Risk Averse

Myth: Venture capitalists are risk takers

Reality: Venture capitalists are relatively risk averse, preferring to take the minimum risks required to achieve the high level of returns that they seek.

Page 30: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Life Cycle of VC Investment

Preparation and submission of business plan

Preliminary assessment of business plan Meet the people Light due diligence Term sheet Heavy due diligence Investment memorandum Commitment Letter Negotiation of shareholder’s agreement Grow the company Exit

Page 31: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Issues in Venture Capital “due diligence”

Technology or service concept Market size and dynamics: subtleties of

markets very important Management team Business model and financial

requirements Valuation and Deal Structure

Page 32: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Financial SupportSeedFinanceSeed

FinanceStart-up

Venture CapitalStart-up

Venture CapitalExpansion

Venture CapitalExpansion

Venture CapitalResearch

GrantsResearch

Grants

Main Role

New FirmNew Firm Mature SMEMature SME Large CompanyLarge Company

ProductProduct

ResearcherResearcher InventorInventor EntrepreneurEntrepreneur BusinessmanBusinessman

Business PlanBusiness Plan

PropositionalKnowledge

PropositionalKnowledge

PrescriptiveKnowledgePrescriptiveKnowledge

BasicResearch

BasicResearch

AppliedResearchApplied

ResearchProduct Design &

DevelopmentProduct Design &

Development ManufacturingManufacturing

Pre-productionPrototype

Pre-productionPrototype

EngineeringPrototype

EngineeringPrototype

Financial SupporterResearchFoundersResearchFounders

AngelInvestors

AngelInvestors

VentureCapital Firm

VentureCapital Firm

Corporate InvestorsBanks

Corporate InvestorsBanks

Page 33: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Expansion Stage

Financing provided for the growth and expansion of a company which is breaking even or trading profitably.

Capital may be used to finance increased production capacity, market or product development and/or to provide additional working capital.

Page 34: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Investment Bank

An Investment Bank is a firm, acting as underwriter or agent that serves as intermediary between an issuer of securities (shares) or bonds and the investing public.

The investment banker, makes outright purchases of new securities from the issuer and distributes them to dealers and investors, profiting on the spread between the purchase price and the selling (public offering) price.

Page 35: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Financial SupportSeedFinanceSeed

FinanceStart-up

Venture CapitalStart-up

Venture CapitalExpansion

Venture CapitalExpansion

Venture CapitalMezzanine

FinanceMezzanine

FinanceResearch

GrantsResearch

Grants

Main Role

New FirmNew Firm Mature SMEMature SME Large CompanyLarge Company

ProductProduct

ResearcherResearcher InventorInventor EntrepreneurEntrepreneur BusinessmanBusinessman

Business PlanBusiness Plan

PropositionalKnowledge

PropositionalKnowledge

PrescriptiveKnowledgePrescriptiveKnowledge

BasicResearch

BasicResearch

AppliedResearchApplied

ResearchProduct Design &

DevelopmentProduct Design &

Development ManufacturingManufacturing

Pre-productionPrototype

Pre-productionPrototype

EngineeringPrototype

EngineeringPrototype

Financial SupporterResearchFoundersResearchFounders

AngelInvestors

AngelInvestors

VentureCapital Firm

VentureCapital Firm

Corporate InvestorsBanks

Corporate InvestorsBanks

IPOAcquisition

IPOAcquisition

Page 36: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Mezzanine (Bridge finance)

Finance made available to a company in the period of transition from being privately owned to being publicly quoted.

Page 37: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Initial Public Offering (IPO)

The first sale of a company's shares to the public

Page 38: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capital Investment

Page 39: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Share of High-tech in Venture Capital

Page 40: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

The US Venture Industry Has Grown

Source: 2004 NVCA Yearbook,/Venture Economics

At Year End

# Venture Firms

Capital Under Mgt

1970 28 $1B 1980 89 $4B 1990 399 $31B 2001 943 $257B 2003 919 $257B

Page 41: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

America’s Job-Creating Engine

Companies backed by venture capital since 1970: Provide 10.1 million US jobs Had 2003 sales of $1.8 trillion

10% of US GDP on under 2% of capital invested

Source: Venture Impact 2004 by Global Insight (Wharton/DRI)

Page 42: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Key Findings For every dollar invested in 1970-

1999, there was $9 in revenue during 2000

For every $21,627 of venture capital investment in 1970-1999, there was one job in the year 2000

Source: DRI-WEFA (analysis as of 8/2001

Page 43: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

The Increasing Role of Startups in U.S.-Led Innovation

Venture backed firms spend twice as much on R&D as non-venture backed firms

Share of US R&D performed by firms with <500 employees: 1984: 5.9% ($4.4B) 2003: 20.7% ($40.1B)

Major source of productivity growth CAD/CAM, JIT, Auto-ID, payments, POS, e-Tailing,

internet travel Major source of U.S. Competitiveness:

72% of all venture capital worldwide is in the US

Page 44: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

Venture Capital in the EU

Funds raised in the EU: € 48 bil UK 37%, Fr 16%, DE 13%, ... High Tech early-stage: € 8.6 bil High Tech expansion/development: € 6.6 bil

Page 45: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Dr. S

hahra

m

Yazd

ani

The German “WFG”

First German venture capital fund. Structure:

Founded by 29 German banks who put up 10 billion DM.

Government guaranteed up to 75% of fund losses.

12 person board = 3 bank, 3 government, 2 industry, 2 management consultants, & two scientists.

Mixed board committee made project selection.

Page 46: Dr. Shahram Yazdani Venture Capital Investment Shahid Beheshti University of Medical Sciences School of Medical Education Strategic Policy Sessions: 08.

Thank You !

Any Question ?